img

Global Weight Loss Therapeutics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Weight Loss Therapeutics Market Insights, Forecast to 2034

Currently, available weight loss mainly therapeutics works by appetite suppression, increasing body metabolism and interfering with the digestion and absorption patterns.
Market Analysis and InsightsGlobal Weight Loss Therapeutics Market
Global Weight Loss Therapeutics market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Weight Loss Therapeutics industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
According to our Wellness & Health Research Center, the global wellness & health economy was valued at US dollars 4.8 trillion. Asia Pacific was the region with the highest spending on big health in 2022, with a total spending of $1.68 trillion, followed by North America ($1.42 trillion) and Europe ($1.0 trillion). According to the health industry accounting analysis data disclosed by the Health Development Research Center of the National Health Commission, from 2019 to 2021, the market size of the health service industry grew by an average of 7.0% per year, and the specific data increased from 7.7 trillion yuan to 8.8 trillion yuan. China's health industry revenue reached 8.0 trillion yuan in 2021, with an increase of 8.1%. According to public information, in 2022, there were about 1.2 billion obesity cases worldwide, among them, the number of obesity cases in China reached 230 million. Wellness & Health Research Center, the global sports economy was valued at 750 billion in 2022, 92% of global spending on physical activity occurs in Asia Pacific, North America and Europe. And China and the United States accounted for 44% of total sports spending.
Report Covers
This report presents an overview of global Weight Loss Therapeutics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Weight Loss Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbott
Sanofi
Novo Nordisk
Arena Pharmaceuticals
Orexigen Therapeutics
Johnson & Johnson
Pfizer
Novartis AG
Biocon
VIVUS
Eli Lilly
Amgen
Zafgen
Roche
Eisai
Segment by Type
Appetite Suppression
Increasing Body Metabolism
Interfering with the Digestion Absorption Patterns

Segment by Application


Hospitals
Specialized Clinics
Retail Pharmacies
Mail Order Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Weight Loss Therapeutics introduction, etc. Weight Loss Therapeutics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Weight Loss Therapeutics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Weight Loss Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Appetite Suppression
1.2.3 Increasing Body Metabolism
1.2.4 Interfering with the Digestion Absorption Patterns
1.3 Market by Application
1.3.1 Global Weight Loss Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Retail Pharmacies
1.3.5 Mail Order Pharmacies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Weight Loss Therapeutics Market Perspective (2018-2033)
2.2 Global Weight Loss Therapeutics Growth Trends by Region
2.2.1 Weight Loss Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Weight Loss Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Weight Loss Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Weight Loss Therapeutics Market Dynamics
2.3.1 Weight Loss Therapeutics Industry Trends
2.3.2 Weight Loss Therapeutics Market Drivers
2.3.3 Weight Loss Therapeutics Market Challenges
2.3.4 Weight Loss Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Weight Loss Therapeutics by Players
3.1.1 Global Weight Loss Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Weight Loss Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Weight Loss Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Weight Loss Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Weight Loss Therapeutics Market Concentration Ratio
3.4.1 Global Weight Loss Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Weight Loss Therapeutics Revenue in 2022
3.5 Global Key Players of Weight Loss Therapeutics Head office and Area Served
3.6 Global Key Players of Weight Loss Therapeutics, Product and Application
3.7 Global Key Players of Weight Loss Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Weight Loss Therapeutics Breakdown Data by Type
4.1 Global Weight Loss Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Weight Loss Therapeutics Forecasted Market Size by Type (2024-2033)
5 Weight Loss Therapeutics Breakdown Data by Application
5.1 Global Weight Loss Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Weight Loss Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Weight Loss Therapeutics Market Size (2018-2033)
6.2 North America Weight Loss Therapeutics Market Size by Type
6.2.1 North America Weight Loss Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Weight Loss Therapeutics Market Size by Type (2024-2033)
6.2.3 North America Weight Loss Therapeutics Market Share by Type (2018-2033)
6.3 North America Weight Loss Therapeutics Market Size by Application
6.3.1 North America Weight Loss Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Weight Loss Therapeutics Market Size by Application (2024-2033)
6.3.3 North America Weight Loss Therapeutics Market Share by Application (2018-2033)
6.4 North America Weight Loss Therapeutics Market Size by Country
6.4.1 North America Weight Loss Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Weight Loss Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Weight Loss Therapeutics Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Weight Loss Therapeutics Market Size (2018-2033)
7.2 Europe Weight Loss Therapeutics Market Size by Type
7.2.1 Europe Weight Loss Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Weight Loss Therapeutics Market Size by Type (2024-2033)
7.2.3 Europe Weight Loss Therapeutics Market Share by Type (2018-2033)
7.3 Europe Weight Loss Therapeutics Market Size by Application
7.3.1 Europe Weight Loss Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Weight Loss Therapeutics Market Size by Application (2024-2033)
7.3.3 Europe Weight Loss Therapeutics Market Share by Application (2018-2033)
7.4 Europe Weight Loss Therapeutics Market Size by Country
7.4.1 Europe Weight Loss Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Weight Loss Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Weight Loss Therapeutics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Weight Loss Therapeutics Market Size (2018-2033)
8.2 China Weight Loss Therapeutics Market Size by Type
8.2.1 China Weight Loss Therapeutics Market Size by Type (2018-2023)
8.2.2 China Weight Loss Therapeutics Market Size by Type (2024-2033)
8.2.3 China Weight Loss Therapeutics Market Share by Type (2018-2033)
8.3 China Weight Loss Therapeutics Market Size by Application
8.3.1 China Weight Loss Therapeutics Market Size by Application (2018-2023)
8.3.2 China Weight Loss Therapeutics Market Size by Application (2024-2033)
8.3.3 China Weight Loss Therapeutics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Weight Loss Therapeutics Market Size (2018-2033)
9.2 Asia Weight Loss Therapeutics Market Size by Type
9.2.1 Asia Weight Loss Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Weight Loss Therapeutics Market Size by Type (2024-2033)
9.2.3 Asia Weight Loss Therapeutics Market Share by Type (2018-2033)
9.3 Asia Weight Loss Therapeutics Market Size by Application
9.3.1 Asia Weight Loss Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Weight Loss Therapeutics Market Size by Application (2024-2033)
9.3.3 Asia Weight Loss Therapeutics Market Share by Application (2018-2033)
9.4 Asia Weight Loss Therapeutics Market Size by Region
9.4.1 Asia Weight Loss Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Weight Loss Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Weight Loss Therapeutics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Weight Loss Therapeutics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Weight Loss Therapeutics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Weight Loss Therapeutics Introduction
11.1.4 Abbott Revenue in Weight Loss Therapeutics Business (2018-2023)
11.1.5 Abbott Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Weight Loss Therapeutics Introduction
11.2.4 Sanofi Revenue in Weight Loss Therapeutics Business (2018-2023)
11.2.5 Sanofi Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Weight Loss Therapeutics Introduction
11.3.4 Novo Nordisk Revenue in Weight Loss Therapeutics Business (2018-2023)
11.3.5 Novo Nordisk Recent Developments
11.4 Arena Pharmaceuticals
11.4.1 Arena Pharmaceuticals Company Details
11.4.2 Arena Pharmaceuticals Business Overview
11.4.3 Arena Pharmaceuticals Weight Loss Therapeutics Introduction
11.4.4 Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2018-2023)
11.4.5 Arena Pharmaceuticals Recent Developments
11.5 Orexigen Therapeutics
11.5.1 Orexigen Therapeutics Company Details
11.5.2 Orexigen Therapeutics Business Overview
11.5.3 Orexigen Therapeutics Weight Loss Therapeutics Introduction
11.5.4 Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2018-2023)
11.5.5 Orexigen Therapeutics Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Weight Loss Therapeutics Introduction
11.6.4 Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2018-2023)
11.6.5 Johnson & Johnson Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Weight Loss Therapeutics Introduction
11.7.4 Pfizer Revenue in Weight Loss Therapeutics Business (2018-2023)
11.7.5 Pfizer Recent Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Weight Loss Therapeutics Introduction
11.8.4 Novartis AG Revenue in Weight Loss Therapeutics Business (2018-2023)
11.8.5 Novartis AG Recent Developments
11.9 Biocon
11.9.1 Biocon Company Details
11.9.2 Biocon Business Overview
11.9.3 Biocon Weight Loss Therapeutics Introduction
11.9.4 Biocon Revenue in Weight Loss Therapeutics Business (2018-2023)
11.9.5 Biocon Recent Developments
11.10 VIVUS
11.10.1 VIVUS Company Details
11.10.2 VIVUS Business Overview
11.10.3 VIVUS Weight Loss Therapeutics Introduction
11.10.4 VIVUS Revenue in Weight Loss Therapeutics Business (2018-2023)
11.10.5 VIVUS Recent Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Weight Loss Therapeutics Introduction
11.11.4 Eli Lilly Revenue in Weight Loss Therapeutics Business (2018-2023)
11.11.5 Eli Lilly Recent Developments
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Weight Loss Therapeutics Introduction
11.12.4 Amgen Revenue in Weight Loss Therapeutics Business (2018-2023)
11.12.5 Amgen Recent Developments
11.13 Zafgen
11.13.1 Zafgen Company Details
11.13.2 Zafgen Business Overview
11.13.3 Zafgen Weight Loss Therapeutics Introduction
11.13.4 Zafgen Revenue in Weight Loss Therapeutics Business (2018-2023)
11.13.5 Zafgen Recent Developments
11.14 Roche
11.14.1 Roche Company Details
11.14.2 Roche Business Overview
11.14.3 Roche Weight Loss Therapeutics Introduction
11.14.4 Roche Revenue in Weight Loss Therapeutics Business (2018-2023)
11.14.5 Roche Recent Developments
11.15 Eisai
11.15.1 Eisai Company Details
11.15.2 Eisai Business Overview
11.15.3 Eisai Weight Loss Therapeutics Introduction
11.15.4 Eisai Revenue in Weight Loss Therapeutics Business (2018-2023)
11.15.5 Eisai Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Weight Loss Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Appetite Suppression
Table 3. Key Players of Increasing Body Metabolism
Table 4. Key Players of Interfering with the Digestion Absorption Patterns
Table 5. Global Weight Loss Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Weight Loss Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Weight Loss Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Weight Loss Therapeutics Market Share by Region (2018-2023)
Table 9. Global Weight Loss Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Weight Loss Therapeutics Market Share by Region (2024-2033)
Table 11. Weight Loss Therapeutics Market Trends
Table 12. Weight Loss Therapeutics Market Drivers
Table 13. Weight Loss Therapeutics Market Challenges
Table 14. Weight Loss Therapeutics Market Restraints
Table 15. Global Weight Loss Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Weight Loss Therapeutics Revenue Share by Players (2018-2023)
Table 17. Global Top Weight Loss Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight Loss Therapeutics as of 2022)
Table 18. Global Weight Loss Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Weight Loss Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Weight Loss Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Weight Loss Therapeutics, Product and Application
Table 22. Global Key Players of Weight Loss Therapeutics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Weight Loss Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Weight Loss Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Weight Loss Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Weight Loss Therapeutics Revenue Market Share by Type (2024-2033)
Table 28. Global Weight Loss Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Weight Loss Therapeutics Revenue Share by Application (2018-2023)
Table 30. Global Weight Loss Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Weight Loss Therapeutics Revenue Share by Application (2024-2033)
Table 32. North America Weight Loss Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Weight Loss Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Weight Loss Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Weight Loss Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Weight Loss Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Weight Loss Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Weight Loss Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Weight Loss Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Weight Loss Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Weight Loss Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Weight Loss Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Weight Loss Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Weight Loss Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Weight Loss Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Weight Loss Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Weight Loss Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Weight Loss Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Weight Loss Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Weight Loss Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Weight Loss Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Weight Loss Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Weight Loss Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Weight Loss Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Weight Loss Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Weight Loss Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Weight Loss Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Weight Loss Therapeutics Product
Table 67. Abbott Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 68. Abbott Recent Developments
Table 69. Sanofi Company Details
Table 70. Sanofi Business Overview
Table 71. Sanofi Weight Loss Therapeutics Product
Table 72. Sanofi Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 73. Sanofi Recent Developments
Table 74. Novo Nordisk Company Details
Table 75. Novo Nordisk Business Overview
Table 76. Novo Nordisk Weight Loss Therapeutics Product
Table 77. Novo Nordisk Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 78. Novo Nordisk Recent Developments
Table 79. Arena Pharmaceuticals Company Details
Table 80. Arena Pharmaceuticals Business Overview
Table 81. Arena Pharmaceuticals Weight Loss Therapeutics Product
Table 82. Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 83. Arena Pharmaceuticals Recent Developments
Table 84. Orexigen Therapeutics Company Details
Table 85. Orexigen Therapeutics Business Overview
Table 86. Orexigen Therapeutics Weight Loss Therapeutics Product
Table 87. Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 88. Orexigen Therapeutics Recent Developments
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Weight Loss Therapeutics Product
Table 92. Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 93. Johnson & Johnson Recent Developments
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Weight Loss Therapeutics Product
Table 97. Pfizer Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 98. Pfizer Recent Developments
Table 99. Novartis AG Company Details
Table 100. Novartis AG Business Overview
Table 101. Novartis AG Weight Loss Therapeutics Product
Table 102. Novartis AG Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 103. Novartis AG Recent Developments
Table 104. Biocon Company Details
Table 105. Biocon Business Overview
Table 106. Biocon Weight Loss Therapeutics Product
Table 107. Biocon Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 108. Biocon Recent Developments
Table 109. VIVUS Company Details
Table 110. VIVUS Business Overview
Table 111. VIVUS Weight Loss Therapeutics Product
Table 112. VIVUS Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 113. VIVUS Recent Developments
Table 114. Eli Lilly Company Details
Table 115. Eli Lilly Business Overview
Table 116. Eli Lilly Weight Loss Therapeutics Product
Table 117. Eli Lilly Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 118. Eli Lilly Recent Developments
Table 119. Amgen Company Details
Table 120. Amgen Business Overview
Table 121. Amgen Weight Loss Therapeutics Product
Table 122. Amgen Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 123. Amgen Recent Developments
Table 124. Zafgen Company Details
Table 125. Zafgen Business Overview
Table 126. Zafgen Weight Loss Therapeutics Product
Table 127. Zafgen Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 128. Zafgen Recent Developments
Table 129. Roche Company Details
Table 130. Roche Business Overview
Table 131. Roche Weight Loss Therapeutics Product
Table 132. Roche Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 133. Roche Recent Developments
Table 134. Eisai Company Details
Table 135. Eisai Business Overview
Table 136. Eisai Weight Loss Therapeutics Product
Table 137. Eisai Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 138. Eisai Recent Developments
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Weight Loss Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Weight Loss Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Appetite Suppression Features
Figure 4. Increasing Body Metabolism Features
Figure 5. Interfering with the Digestion Absorption Patterns Features
Figure 6. Global Weight Loss Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Weight Loss Therapeutics Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Specialized Clinics Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Mail Order Pharmacies Case Studies
Figure 12. Others Case Studies
Figure 13. Weight Loss Therapeutics Report Years Considered
Figure 14. Global Weight Loss Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Weight Loss Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Weight Loss Therapeutics Market Share by Region: 2022 VS 2033
Figure 17. Global Weight Loss Therapeutics Market Share by Players in 2022
Figure 18. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight Loss Therapeutics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Weight Loss Therapeutics Revenue in 2022
Figure 20. North America Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Weight Loss Therapeutics Market Share by Type (2018-2033)
Figure 22. North America Weight Loss Therapeutics Market Share by Application (2018-2033)
Figure 23. North America Weight Loss Therapeutics Market Share by Country (2018-2033)
Figure 24. United States Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Weight Loss Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe Weight Loss Therapeutics Market Share by Type (2018-2033)
Figure 28. Europe Weight Loss Therapeutics Market Share by Application (2018-2033)
Figure 29. Europe Weight Loss Therapeutics Market Share by Country (2018-2033)
Figure 30. Germany Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China Weight Loss Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China Weight Loss Therapeutics Market Share by Type (2018-2033)
Figure 38. China Weight Loss Therapeutics Market Share by Application (2018-2033)
Figure 39. Asia Weight Loss Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia Weight Loss Therapeutics Market Share by Type (2018-2033)
Figure 41. Asia Weight Loss Therapeutics Market Share by Application (2018-2033)
Figure 42. Asia Weight Loss Therapeutics Market Share by Region (2018-2033)
Figure 43. Japan Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Weight Loss Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Weight Loss Therapeutics Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America Weight Loss Therapeutics Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America Weight Loss Therapeutics Market Share by Country (2018-2033)
Figure 53. Brazil Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries Weight Loss Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 60. Sanofi Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 61. Novo Nordisk Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 62. Arena Pharmaceuticals Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 63. Orexigen Therapeutics Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 64. Johnson & Johnson Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 65. Pfizer Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 66. Novartis AG Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 67. Biocon Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 68. VIVUS Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 69. Eli Lilly Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 70. Amgen Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 71. Zafgen Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 72. Roche Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 73. Eisai Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries